FdaApplication

NDA 218754

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAZURITY PHARMACEUTICALS INC
application_typeNDA
approval_date2026-06-16

Products (1)

ProductActive ingredientStrengthDosage form
APREPITANTAPREPITANT130MG/18ML (7.2MG/ML)EMULSION;INTRAVENOUS

1 product